Kyverna Therapeutics, Inc.·4

Jan 24, 8:05 PM ET

GEHCHAN NAJI 4

4 · Kyverna Therapeutics, Inc. · Filed Jan 24, 2025

Insider Transaction Report

Form 4
Period: 2025-01-22
GEHCHAN NAJI
See Remarks
Transactions
  • Award

    Stock Option (right to buy)

    2025-01-22+425,000425,000 total
    Exercise: $3.29Exp: 2035-01-22Common Stock (425,000 underlying)
Footnotes (1)
  • [F1]1/4th of the shares subject to the option shall vest on January 22, 2026, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4